Lyophilization Equipment and Services Market Size Analysis, Growth Trends & Forecast to 2034

Lyophilization Equipment and Services Market Overview 

The global lyophilization equipment and services market was valued at USD 5.6 billion in 2026 and is projected to reach USD 11.2 billion by 2034, expanding at a CAGR of 9.4% during the forecast period.  The lyophilization equipment & services market is composed of assorted materials such as freeze-drying equipment, consumables, and accessories linked to the preservation of pharmaceuticals, biologics, diagnostics, and food products from being spoiled. The growth of this market is attributed to increasing demand for biologics and vaccines, injectable drugs, as well as contract manufacturing services, and enhanced capacity to manufacture pharmaceuticals and biotechnology products.

Advancements in technology such as automatic lyophilization systems, energy-efficient systems, digital control systems, and maintenance/validation services have also contributed to the growth of this market.

Lyophilization Equipment and Services Market Drivers and Opportunities

Growing Demand for Biologics and Injectable Therapeutics is Driving Market Growth

The growth in the development and production of biologics, vaccines, monoclonal antibodies, cell & gene therapy products, and other sensitive and injectable drug products will play a crucial role in the increased demand for lyophilization equipment. Lyophilization technology has an essential contribution to the preservation of stability, efficacy, and shelf life of such drugs without continuous cold chain transportation requirements, thus facilitating global shipment of these products. With the growing pipeline of biologics by the pharmaceuticals and biotechnology firms and investment in scale-up manufacturing, there is a growing demand for more efficient lyophilization systems. For example, in July 2026, a subsidiary of Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals International GmbH, and Polpharma Biologics International AG signed a global licensing agreement, according to which Teva received exclusive commercialization rights for both formulations of Polpharma Biologics' biosimilar to Ocrevus (ocrelizumab), provided that all regulatory approvals have been received. This partnership demonstrates an expansion in the market for biosimilars and biologics that is anticipated to result in increased demand for aseptic manufacturing and lyophilization technologies.

Expansion of Pharmaceutical and Biotechnology Manufacturing Capacity Fueling Market Expansion

There is an increasing number of investments in pharmaceutical manufacturing facilities, CDMOs/CRDMOs, and sterile production equipment. With the expansion of capacity for the production of biologics, peptides, injectables, and other high-value therapies, there is also an increasing demand for lyophilization systems on laboratory, pilot, and industrial scales, along with installation, validation, qualification, and maintenance services. For example, Lupin Manufacturing Solutions (LMS), the global CRDMO belonging to Lupin Limited and specializing in the peptide building blocks platform and CRDMO services, announced the expansion of its Dabhasa manufacturing facility in March 2026. In particular, the company will expand its facilities with a new manufacturing block and two peptide production units, which demonstrates the current tendency towards the development of specialized pharmaceutical manufacturing facilities.

Increasing Adoption of Automated and Continuous Lyophilization Technologies Presents Significant Opportunities

The increasing focus on production efficiency, automated processes, and regulatory adherence is providing significant opportunities for manufacturers of advanced lyophilization equipment. More and more pharmaceutical and biotechnology companies are utilizing automated and continuously operating freeze-drying technologies that feature real-time process monitoring capabilities, use of PAT technology, and robotic systems for loading and unloading processes to ensure better batch consistency and speed of production while cutting costs. Moreover, the growing need for energy-efficient and sustainable manufacturing processes increases the demand for next-generation lyophilizers characterized by less energy usage and a smaller environmental footprint.

Lyophilization Equipment and Services Market Scope

Lyophilization Equipment and Services Market Report Segmentation Analysis

The global lyophilization equipment and services market industry analysis is segmented by modality, scale of operation, end user, and region. 

Consumables & Accessories Segment Is Expected to Dominate the Lyophilization Equipment and Services Market During the Forecast Period

The lyophilization equipment and services market is anticipated to be dominated by the consumables and accessories segment due to the recurring requirement of trays, vials, stoppers, filters, seals, manifolds, and other replacement parts used in each freeze-drying cycle. The increase in the production of biologics, vaccines, injectable medicines, and other sterile pharmaceuticals is the driving force behind the continuing use of these products in compliance with GMP regulations, as well as in ensuring efficiency and quality in manufacturing processes. Moreover, it is expected that the growing capacity of pharmaceutical manufacturing and continuous CDMO development, as well as the regular maintenance and validation of equipment, will ensure stable demand for consumables and accessories during the entire forecast period.

Industry Scale Segment Is Expected to Lead the Lyophilization Equipment and Services Market by Scale of Operation

The segment of lyophilization equipment and services most likely to become the leader is Industry Scale. This arises from the increase in the commercial production of biologics, vaccines, injectable pharmaceutical products, etc. Different major biotech and pharmaceutical companies invest in high-capacity lyophilization systems to enhance their production efficiency and ensure compliance with regulations in the area of the production of biopharmaceuticals. The expansion of commercial manufacturing activities, CDMO operations, and CRDMO activities is likely to strengthen the position of the Industry Scale segment as well.

Pharmaceutical & Biotechnology Companies Segment Is Expected to Dominate the End User Segment

The pharmaceutical and biotechnology segment is projected to account for the largest share of the lyophilization equipment & services market, attributable to the growing need for the utilization of freeze-drying in the development and commercialization of biologics, vaccines, injectable drugs, peptides, and advanced therapy products. These companies are focusing on making significant investments in the expansion of sterile production capabilities and adoption of modern technology in lyophilization. For example, in March 2026, OFD Life Sciences, Inc., a division of Oregon Freeze Dry, was granted a patent for its LyoPastille oral delivery system. This technology has over six decades of experience in lyophilization and is used for producing orally dissolving tablets that are more absorbable and easily bioavailable than other products. The technology shows the wide application of lyophilization technologies in biopharmaceuticals, medtech, animal health, and consumer health.

The following segments are part of an in-depth analysis of the global lyophilization equipment and services market:

Lyophilization Equipment and Services Market Share Analysis by Region

North America is projected to hold the largest share of the global lyophilization equipment and services market over the forecast period  

North America is predicted to hold major shares of the global market for lyophilization equipment and services due to the existence of key pharmaceutical and biotech companies, state-of-the-art biologics manufacturing infrastructure, and high investments in sterile injection production. The reason for the advantage of this market is the continuous development of biologics and biosimilars, along with a well-established CDMO network and stringent regulations, contributing to the growth of advanced GMP-compliant lyophilization technologies. It is also worth mentioning the continuous investment made to manufacture more, innovate technologies, and prosper with various equipment and service producers.

Lyophilization Equipment and Services Market Competition Landscape Analysis

The market for lyophilization equipment and services comprises major producers of freeze-drying hardware and supplies, offering solutions and services primarily to biopharma companies, CROs/CDMOs, laboratory researchers, diagnostics companies, food producers, and other businesses in the life sciences sector. In order to strengthen their competitive position on the market, companies are implementing innovations in automated and continuous lyophilization systems, power-efficient freeze-drying technologies, robotic loading/unloading systems, PAT solutions, and digital monitoring systems for optimization of processes and compliance with regulations.

Organizations are increasing their market share through various ways, including joint ventures, launching new products, expanding production capacities, obtaining licenses, merging with other organizations, and enhancing investments in R&D activities. 

Global Lyophilization Equipment and Services Market Recent Developments News:

●        In March 2026 - BioTechnique, a full-service CRDMO, announced expanded aseptic fill-finish and lyophilization capabilities supporting pharmaceutical programs from development through commercial supply. These services are integrated with BioTechnique’s third-party logistics and storage platform, offering controlled warehousing across ambient (15–25°C), refrigerated (2–8°C), frozen (−20°C), ultralow (−80°C), and cryogenic (−190°C) conditions.

●        In August 2025 -  Cytiva and Argonaut Manufacturing Services announced a strategic collaboration across the U.S. and Europe to expand lyophilization and reagent stabilization services, enhancing localized manufacturing capabilities, improving production scalability, and increasing cost efficiency for diagnostic developers.

●        In July 2024 - GEA showcased its latest pharmaceutical freeze-drying innovations at ACHEMA 2024 in Frankfurt, Germany, featuring LYOAIR, LYOVAC ECO Mode, and microwave-assisted freeze-drying technologies designed to improve energy efficiency, enhance sustainability, and optimize pharmaceutical production performance.

The global lyophilization equipment and services market is dominated by a few large companies, such as

●        Biopharma Process Systems

●        Büchi Labortechnik

●        Cryotec FR

●        Cuddon Freeze Dry

●        GEA Group AG

●        GEA Group Aktiengesellschaft

●        Harvest Right

●        HOF Sonderanlagenbau

●        IMA S.p.A.

●        IMA S.p.A.

●        Labconco Corporation

●        Martin Christ Gefriertrocknungsanlagen GmbH

●        Millrock Technology

●        Optima Packaging Group GmbH

●        SP Industries (ATS Scientific Products)

●        SP Industries (ATS)

●        Tofflon Science & Technology

●        Tofflon Science & Technology Co., Ltd.

●        Vikumer Freeze-Dry

●        ZIRBUS Technology

●        Other Prominent Players